SUBSCRIBE
SUBSCRIBE

Canada

Novartis head office building in Dorval, Quebec, Canada
Business
Novartis, Versant Launch RNA Kidney Medicines—Focused Borealis
Looking to build on the success of Chinook Therapeutics, founded by Versant in 2019 and acquired by Novartis last year, the companies on Thursday launched Borealis Biosciences with $150 million in funding to develop RNA therapeutics for kidney diseases.
August 22, 2024
 · 
2 min read
 · 
Kate Goodwin
Agilent's signage at its office in California
Mergers & acquisitions
Agilent Pays $925M to Buy CDMO Biovectra to Boost Biologics, CRISPR Capabilities
The acquisition of the contract development and manufacturing organization will allow Agilent Technologies to provide a one-stop source for gene-editing services for its customers.
July 23, 2024
 · 
2 min read
 · 
Tristan Manalac
PRESS RELEASES
Press Releases
CareRx Reports Results for the Third Quarter of 2024
November 8, 2024
 · 
10 min read
Press Releases
Medicenna Presents Preclinical Data from its Anti-PD1-IL-2 BiSKIT and IL-2 Super Agonist Programs at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
November 8, 2024
 · 
8 min read
Press Releases
BriaCell Showcases Robust Anti-Cancer Activity of Personalized Off-the-Shelf Immunotherapy Pipeline at the 2024 SITC Conference
November 8, 2024
 · 
7 min read
Press Releases
Perimeter Medical Imaging AI to Report Third Quarter 2024 Financial Results and Host Conference Call on November 14, 2024
November 8, 2024
 · 
4 min read
Press Releases
Spectral Medical Announces Third Quarter Results and Provides Corporate Update
November 8, 2024
 · 
16 min read
Press Releases
HLS Therapeutics Announces Q3 2024 Financial Results
November 8, 2024
 · 
18 min read
Press Releases
Lexaria Updates Fast-Moving GLP-1 ‘Arm’s Race’ Developments
November 8, 2024
 · 
7 min read
Press Releases
Profound Medical Announces Third Quarter 2024 Financial Results
November 8, 2024
 · 
15 min read
Press Releases
Achieve Life Sciences Reports Financial Results for Third Quarter 2024 and Provides Corporate Update
November 8, 2024
 · 
10 min read
Press Releases
Eupraxia Pharmaceuticals Reports Third Quarter 2024 Financial Results
November 7, 2024
 · 
9 min read
Press Releases
Cipher Pharmaceuticals Reports Third Quarter 2024 Results
November 7, 2024
 · 
16 min read
Press Releases
Medexus Announces Strong Fiscal Q2 2025 Results
November 7, 2024
 · 
23 min read
Press Releases
AbCellera Presents Data on Applications of T-Cell Engager Platform at SITC 2024
November 7, 2024
 · 
4 min read
Press Releases
BioHarvest Sciences Announces Uplisting to the Nasdaq Global Market
November 7, 2024
 · 
3 min read
Press Releases
Marvel Biosciences Announces MB204 Outperforms Approved Drug Trofinetide in a Preclinical Model of Rett Syndrome
November 7, 2024
 · 
5 min read
Press Releases
NervGen Pharma to Present at the Stifel 2024 Healthcare Conference
November 7, 2024
 · 
5 min read
Press Releases
Bionoid Pharma, Inc. Engages Olayinka Oyebola & Co. as PCAOB External Auditor for Annual Financial Audit
November 7, 2024
 · 
1 min read
Press Releases
Augurex to Present Axial Spondyloarthritis Data and Exhibit at ACR Convergence 2024 in Washington, DC
November 7, 2024
 · 
3 min read
Press Releases
Repare Therapeutics Provides Business and Clinical Update and Reports Third Quarter 2024 Financial Results
November 7, 2024
 · 
13 min read
Press Releases
Aurinia Pharmaceuticals Reports Third Quarter and Nine Months 2024 Financial and Operational Results, Announces Strategic Restructuring to Sharpen Focus on Continued LUPKYNIS® Growth and AUR200 Development
November 7, 2024
 · 
16 min read
Load More